showed a trendp=0.051
Although the difference did not reach statistical significance, bevacizumab showed a trend toward improved survival (p=0.051, Figure 5B ).
Although the difference did not reach statistical significance, bevacizumab showed a trend toward improved survival (p=0.051, Figure 5B ).